In this episode of The Pulse podcast, Sandy interviews Nancy Yu, Co-Founder and CEO of RDMD, about making drug research, development and commercialization faster, cheaper, and better. Backed by Lux Capital and Village Global, RDMD is a healthcare technology company dedicated to accelerating treatments for patients with rare diseases. RDMD has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to get access to and benefit from their own medical data. Nancy’s prior experience includes leading Corporate Development at 23andMe, consulting for Livongo, biopharma banking and private equity. Nancy also graduated from the University of Pennsylvania.
The Pulse by Wharton Digital Health